In addition to their significant effectiveness in glycemic control and weight/fat mass reduction, theyve also been shown to decrease the risk of heart disease, heart failure, stroke and kidney disease
Melanocortin Receptors and Their Roles in Obesity, Appetite, and Energy Regulation
Beyond-use periods must follow the SmPC : Generic claims about multi-dose vials remaining usable for a fixed number of days are not appropriate
Due to the dual pathway mechanism of Tirzepatide, this medication has greater effects on blood sugar levels and weight loss than Semaglutide (Ozempic)
View Study [5]"Efficacy and safety of CagriSema in type 2 diabetes" Frias JP et al., 2023 Finding: In people with type 2 diabetes, CagriSema achieved 15.6% weight loss versus 5.1% with semaglutide alone over 32 weeks, with comparable HbA1c reductions and good tolerability